About Mitosense
Mitosense is a private company based in Plymouth, Massachusetts. It has reported $4,429,251 raised in three offerings on Form D since February 2020. Its chief executive is Brent Segal.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Jan 11, 2024 | Jan 26, 2024amended May 2, 2025 | $3,654,251fully sold | 16 | $228K | EquityRule 506(b) | Form D/A ↗1 earlier filing |
| Aug 1, 2022 | Aug 8, 2022amended Feb 27, 2023 | $435,000of $7.3M target | 4 | $108K | CONVERTIBLE PROMISSORY NOTES CONVERTIBLE INTO EQUITY SECURITIESRule 506(b) | Form D/A ↗1 earlier filing |
| Feb 14, 2020 | Feb 25, 2020amended Feb 1, 2021 | $340,000of $5.0M target | 9 | $37,778 | Convertible Promissory Notes convertible into Equity SecuritiesRule 506(b) | Form D/A ↗2 earlier filings |
| Total, three offerings | $4,429,251 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Mitosense's Form D filed May 2, 2025.
RW
Richard Waldo
Director
BS
Brent Segal
Chief Executive Officer and director
CB
Catherine Baucom
Executive officer and director
VJ
Van Hipp Jr.
Executive officer and director
XJ
Xianpeng Jiang
Executive officer and director
Earlier filings also listed Tidal Mccoy (vice chairman & chief executive officer, last listed Feb 2021), Carla York (executive officer, last listed Feb 2021) and Andrew Finn (executive officer and director, last listed Feb 2021).